The Epilepsy Therapy Project invests in conferences and website resources to bring researchers and companies together to make new therapies a reality, and is proud to support the three leading world-wide conferences on epilepsy therapy development; Antiepileptic Drug Trials Symposium (AED 1-X); Eilat Conferences on Antiepileptic Drugs and the Epilepsy Pipeline Update Conference.
Antiepileptic Drug Trials XII Conference
May 15-17, 2013
2012 Epilepsy Pipeline Update Conference
February 2-4, 2012
San Francisco, CA
Antiepileptic Drug Trials XI Conference
April 27-29, 2011
Global Symposium on the Dietary Treatments of Epilepsy and other Neurological Disorders
October 5-8, 2010
Edinburgh, Scotland, UK
Epilepsy and Depressive Disorders: An Epilepsy & Behavior conference
September 12-13, 2010
Tenth Eilat Conference on New Antiepileptic Drugs (EILAT X)
April 25-29, 2010
2010 Epilepsy Pipeline Update: Portal Into CNS Conference
February 25-26, 2010
San Francisco, CA
Antiepileptic Drug Trials X
April 15-17, 2009
Coral Gables, Florida
Sponsored by the New York University Medical Center and The Epilepsy Study Consortium as well as the University of Pennsylvania Epilepsy Center and The Epilepsy Therapy Project. Read more.
Sunday, October 26, 2008
9:00am to 4:30pm
NYU Langone Medical Center
550 First Avenue
New York, NY 10016
This annual one day symposium brought together world renowned doctors and researchers to present cutting edge information on the treatment of Epilepsy and Seizures to patients and their caregivers. Read more.
Epilepsy Innovation Summit
Sponsored by the Center for Integration of Medicine and Innovative Technology and the Neurotechnology Industry Organization, and supported by an unrestricted educational grant from the Epilepsy Therapy Project, the Epilepsy Innovation Summit was held May 7, 2008 in Boston, Massachusetts. It brought together clinicians, scientists, engineers, entrepreneurs and the investment community. Speakers showcased emerging and synergistic technologies under development for 1) pre-surgical evaluation, 2) seizure prediction and detection, and 3) intracranial and extracranial treatment systems.